Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma. [PDF]
Davidson B +6 more
europepmc +1 more source
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279. [PDF]
Horowitz NS +16 more
europepmc +1 more source
Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma. [PDF]
Pouwer AW +9 more
europepmc +1 more source
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1). [PDF]
Macchia G +21 more
europepmc +1 more source
Related searches:
Putative precancerous lesions of vulvar squamous cell carcinoma
Seminars in Diagnostic Pathology, 2021Precursor lesions of vulvar squamous cell carcinoma (VSCC) can be divided into two major biologic and prognostic groups: HPV-associated and HPV-independent VSCC. These two pathways are categorized as usual vulvar intraepithelial neoplasia (uVIN) with progression to basaloid or warty VSCC and differentiated vulvar intraepithelial neoplasia (dVIN) with ...
Anne M Mills
exaly +3 more sources
Margin status revisited in vulvar squamous cell carcinoma [PDF]
To determine the incidence of local recurrence of vulvar squamous cell carcinoma in relation to tumor- and/or precursor lesion free pathologic margins.Consecutive patients with primary vulvar squamous cell carcinoma surgically treated in two Dutch expert centers between 2000 and 2010 were included.
Johan Bulten +2 more
exaly +5 more sources
Vulvar squamous cell carcinoma
Expert Review of Obstetrics and Gynecology, 2009Vulvar squamous cell carcinomas account for 90% of all vulvar cancers and originate following two different pathways. Approximately 20% of all vulvar squamous cell carcinomas are caused by an infection with high-risk human papillomavirus. It has been hypothesized that most of these vulvar cancers may be prevented by the recently introduced human ...
Hedwig P van de Nieuwenhof
exaly +2 more sources
Genomic characterization of vulvar squamous cell carcinoma
Gynecologic Oncology, 2020Despite increasing incidence, vulvar squamous cell carcinoma (VSCC) is still a rare disease. Until now, two etiological pathways have been described: a high-risk human papillomavirus (HPV)-dependent route and an HPV-independent pathway often associated with lichen sclerosus.
Katharina, Prieske +8 more
openaire +2 more sources
Langerhans cells in vulvar lichen sclerosus and vulvar squamous cell carcinoma
Archivum Immunologiae et Therapiae Experimentalis, 2006Langerhans cells (LCs), specializing in antigen presentation, are a very important part of the skin immune system (SIS).Skin biopsies from 22 women with vulvar lichen sclerosus (LS): 15 patients with early and 7 with the late stage of the disease, were evaluated. Five women with vulvar squamous cell carcinoma (SCC) were also examined. The control group
Helena, Rotsztejn +2 more
openaire +2 more sources
Vulvar squamous cell carcinoma and lichen sclerosus
Australasian Journal of Dermatology, 1997There are two clinicopathological types of vulvar squamous cell carcinoma, human papillomavirus (HPV)-positive and HPV-negative, which can be distinguished to some degree on routine histology. Human papillomavirus-positive carcinomas account for one-quarter to one-third of cases, occur in women on average 20 years younger than in HPV-negative, and are ...
J P, Scurry, K, Vanin
openaire +2 more sources

